Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
398.3 USD | -0.61% | +1.33% | -2.01% |
12:26pm | Wolfe Research Adjusts Price Target on Vertex Pharmaceuticals to $497 From $515 | MT |
Apr. 23 | Vertex Pharmaceuticals in T1D Licensing Pact With TreeFrog Therapeutics | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.01% | 104B | |
+1.94% | 97.42B | |
+0.79% | 22.2B | |
-17.78% | 21.23B | |
-11.11% | 18.33B | |
-42.83% | 16.35B | |
-16.00% | 15.06B | |
+4.05% | 13.98B | |
+34.81% | 11.66B | |
-26.57% | 8.22B |
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- Vertex Pharmaceuticals : SVB Leerink Adjusts Price Target on Vertex Pharmaceuticals to $250 From $257, Maintains Market Perform Rating